Found: 51
Select item for more details and to access through your institution.
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 797, doi. 10.1002/ajh.24774
- By:
- Publication type:
- Article
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 82, doi. 10.1002/ajh.24591
- By:
- Publication type:
- Article
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 617, doi. 10.1002/ajh.24362
- By:
- Publication type:
- Article
Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 12, p. 960, doi. 10.1002/ajh.21871
- By:
- Publication type:
- Article
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5027, doi. 10.3390/cancers15205027
- By:
- Publication type:
- Article
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3859, doi. 10.3390/cancers15153859
- By:
- Publication type:
- Article
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3706, doi. 10.3390/cancers15143706
- By:
- Publication type:
- Article
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating Endothelial Cells in Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 8, p. 1926, doi. 10.1002/cncr.24961
- By:
- Publication type:
- Article
Indolent T-cell prolymphocytic leukemia: A case report.
- Published in:
- American Journal of Hematology, 2003, v. 74, n. 2, p. 145, doi. 10.1002/ajh.10398
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
- By:
- Publication type:
- Article
Detection of inherited chromosomally integrated HHV-6 (ci HHV-6) in a marker chromosome.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 6, p. 635, doi. 10.1111/ejh.12872
- By:
- Publication type:
- Article
Leucemia mieloide acuta con alterazioni mielodisplastiche in soggetto di 65 anni trattato con CPX-351.
- Published in:
- Current Therapeutics, 2021, v. 24, n. 7, p. 10
- By:
- Publication type:
- Article
A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results.
- Published in:
- Genes, 2020, v. 11, n. 12, p. 1453, doi. 10.3390/genes11121453
- By:
- Publication type:
- Article
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 2, p. 363, doi. 10.1002/hon.2020
- By:
- Publication type:
- Article
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 3, p. 247, doi. 10.1002/cyto.b.21267
- By:
- Publication type:
- Article
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1270, doi. 10.1002/cncr.35156
- By:
- Publication type:
- Article
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic‐phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2637, doi. 10.1002/cncr.34923
- By:
- Publication type:
- Article
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1704, doi. 10.1002/cncr.34722
- By:
- Publication type:
- Article
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2449, doi. 10.1002/cncr.34216
- By:
- Publication type:
- Article
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2657, doi. 10.1002/cncr.33541
- By:
- Publication type:
- Article
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 559, doi. 10.1111/bjh.17890
- By:
- Publication type:
- Article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1068, doi. 10.1111/bjh.16865
- By:
- Publication type:
- Article
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 35, doi. 10.1111/bjh.15497
- By:
- Publication type:
- Article
Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.
- Published in:
- 2014
- By:
- Publication type:
- Report
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 10, p. 1563, doi. 10.1007/s00277-012-1500-8
- By:
- Publication type:
- Article
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 818, doi. 10.1002/gcc.22293
- By:
- Publication type:
- Article
PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B‐NHL with complex chromosomal rearrangementsThis text presents research results of the Belgian program of Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming. The scientific responsibility is assumed by the authors.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 44, n. 2, p. 218, doi. 10.1002/gcc.20214
- By:
- Publication type:
- Article
Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Study.
- Published in:
- Drugs & Aging, 2013, v. 30, n. 8, p. 629, doi. 10.1007/s40266-013-0088-6
- By:
- Publication type:
- Article
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 326, doi. 10.1002/hon.2861
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 409, doi. 10.1002/hon.2843
- By:
- Publication type:
- Article
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MicroRNAs involvement in fludarabine refractorychronic lymphocytic leukemia.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 123, doi. 10.1186/1476-4598-9-123
- By:
- Publication type:
- Article
Acute human herpesvirus-6A infection of human mesothelial cells modulates HLA molecules.
- Published in:
- Archives of Virology, 2015, v. 160, n. 9, p. 2141, doi. 10.1007/s00705-015-2490-3
- By:
- Publication type:
- Article
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 555, doi. 10.1002/cam4.226
- By:
- Publication type:
- Article
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0320-z
- By:
- Publication type:
- Article
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 823, doi. 10.1007/s11523-021-00831-4
- By:
- Publication type:
- Article
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma.
- Published in:
- Journal of Biomedicine & Biotechnology, 2011, p. 1, doi. 10.1155/2011/691493
- By:
- Publication type:
- Article
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.
- Published in:
- Scientific Reports, 2016, p. 26280, doi. 10.1038/srep26280
- By:
- Publication type:
- Article
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 4, p. 529, doi. 10.1111/j.1365-2141.2008.07227.x
- By:
- Publication type:
- Article
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 6, p. 953, doi. 10.1046/j.1365-2141.2003.04176.x
- By:
- Publication type:
- Article
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May–Grunwald–Giemsa-stained bone marrow samples.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 3, p. 652, doi. 10.1046/j.1365-2141.2002.03867.x
- By:
- Publication type:
- Article